TI
SNDX icon

Telemetry Investments’s Syndax Pharmaceuticals SNDX Stock Holding History

Telemetry Investments’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,000
Closed -$174K – 186
2022
Q1 		$174K Buy
+10,000
New +$168K 0.28% 98
2019
Q4 		– Sell
-13,000
Closed -$97K – 51
2019
Q3 		$97K Buy
+13,000
New +$118K 0.3% 50
2019
Q2 		– Sell
-25,000
Closed -$131K – 123
2019
Q1 		$131K Sell
25,000
-25,000
-50% -$143K 0.26% 87
2018
Q4 		$222K Buy
50,000
+26,947
+117% +$148K 0.3% 109
2018
Q3 		$186K Sell
23,053
-25,947
-53% -$185K 0.28% 101
2018
Q2 		$344K Buy
+49,000
New +$481K 0.41% 77

Other funds holding SNDX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return